Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Sarcoma • Medical Oncology

What is your preferred first line systemic therapy for metastatic chordoma?

Mets to spine and s/p RT

Related Questions

What factors do you consider when choosing between vimseltinib and pexidartinib for tenosynovial giant cell tumor (TGCT) patients?

How do you approach adjuvant therapy for resected Stage I Ewing sarcoma of the kidney, and what chemotherapy regimen and cycle duration do you recommend?

How do you approach an otherwise healthy patient with an incidental 1 mm GIST involving the serosal surface in terms of staging workup, EGD, and surveillance?

Is there a role for adjuvant chemotherapy in a young healthy patient with a large malignant phyllodes tumor of the breast with positive margins?

How would you treat a patient with concurrent diagnoses of symptomatic multiple myeloma and a newly diagnosed upper extremity undifferentiated pleomorphic sarcoma?

How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?

How would you treat a primary angiosarcoma arising in the skull, excised with initial excisional biopsy?

Which patient characteristics or clinical factors guide the decision to use Doxorubicin and Trabectedin as first-line treatment for metastatic or unresectable leiomyosarcoma?

How do you approach adjuvant chemotherapy in an adult with localized osteosarcoma who demonstrates 50–90% tumor necrosis on surgical pathology following neoadjuvant doxorubicin and cisplatin?

What is the preferred systemic therapy regimen for a patient in their 40s with untreated metastatic sarcomatoid carcinoma of unknown primary, presenting with hepatic lesions, abdominal lymphadenopathy, and a lytic bone lesion?

Copyright © 2025 theMednet
All Rights Reserved.